Speaker Profile
MD, PhD, Associate Professor, Dept. of Laboratory Medicine, UCSF
Biography
Dr. Wiita is a Clinical Pathologist and physician scientist with research focus on the development of novel immunotherapies for blood cancers. His group aims to integrate mass spectrometry based proteomics, chemical biology, protein engineering, and cellular engineering to treat these diseases. His group specifically focuses on target discovery to overcome poor prognosis or refractory forms of hematologic malignancies via novel cellular therapies. Dr. Wiita completed his undergraduate degree in Chemistry at Princeton, his MDPhD with graduate training in biophysics at Columbia, and residency training in Laboratory Medicine at UCSF. He is a prior recipient of the NIH Director's New Innovator Award, Doris Duke Charitable Foundation Clinical Scientist Development Award, and a Chan Zuckerberg Biohub Investigator Award, among others.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Sharon Benzeno, Adaptive Biotechnologies
- PMWC 2024 Award Ceremony
Pioneer Honoree: Stanley Riddell, Fred Hutchinson
Pioneer Honoree: George Coukos, Ludwig Cancer Center
- Keynote: Engineering Synthetic T Cell States for Cancer Rejection
- George Coukos, Ludwig Cancer Center
- Discovery of Novel Targets in Cell Therapies in Oncology and Autoimmune Disorders (PANEL)
Chair: Harlan Robins, Adaptive Bio
- Stanley Riddell, Fred Hutchinson
- Allison Betof Warner, Stanford
- Lawrence Fong, UCSF - Supply Chain 2.0 Getting Cell Therapies to Patients (PANEL)
Chair: Jean Xu, Janssen Pharmaceuticals
- Amanda Pace, Sonoma Bio
- Laura Deschenes, Sana Biotechnology - Evolving Case Law and Practical Strategies for Immunotherapy Patents
- Janet Xiao, Morrison & Foerster LLP
- Emerging Clinical Data in Oncology Cell Therapeutics
Chair: Andrew Allen, Gritstone bio, Inc.
- Robert Meehan, Moderna - Scientific Advancements in Individualized Cell Therapies in Oncology ( PANEL)
Chair: Sharon Benzeno, Adaptive Biotechnologies
- Ira Mellman, Genenetch
- Robert Meehan, Moderna
- Dirk Nagorsen, Affini-T Therapeutics - AI-Enhanced Approaches in Cell Therapy Development
Chair: Suchit Jhunjhunwala, Genentech
- Brian Weitzner, Outpace Bio
- PMWC Showcase
- Arun Wiita, UCSF
